newsfilter
← Latest News
GlobeNewswire·

Antares Pharma Announces Oral Presentation at the 22nd Annual Fall Scientific Meeting of SMSNA

EWING, N.J., Oct. 25, 2021 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ:ATRS) (the "Company"), a specialty pharmaceutical company, today announced that an abstract on XYOSTED®, a subcutaneous testosterone enanthate injection, was accepted as on or